BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

6:11 PM
 | 
Apr 06, 2009
 |  BC Extra  |  Company News

FDA accepts telavancin NDA for HAP

FDA accepted for filing an NDA for telavancin from Theravance Inc. (NASDAQ:THRX) to treat hospital-acquired pneumonia (HAP) caused by Gram-positive bacteria....

Read the full 92 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >